Atlas Trials

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

Clinical trial NCT06979362 · RECRUITING

Trial details

NCT number
NCT06979362
Sponsor
Novo Nordisk A/S
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Heart Failure
Start date
2025-06-27
Primary completion
2027-11-16
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.